Nemaura Medical Investor Presentation Deck

Future Targets ▪ Launch sugarBEAT® as a standlone medical device CGM sensor in UK and KSA Complete development of Lactate sensor and partner/license sensor for sports/personal training market ▪ Partner Miboko in global territories with focus on USA ▪ Achieve FDA PMA approval for 24-hour sugarBEATⓇ sensor ■

View entire presentation